What Is Retatrutide? NP-III (RT) Triple Agonist Research Guide

Retatrutide (research code LY3437943) is an investigational peptide developed by Eli Lilly that activates three metabolic hormone receptors — GIP, GLP-1, and glucagon — in a single molecule. Nicknamed the “triple G” agonist, it is the first triple incretin-based candidate to reach Phase 3 clinical trials, and its published results have made it one of […]

